Search Results

OncoDNA Announces Expansion of Its Services Into the United States

OncoDNA, a theranostic and genomic company specializing in precision oncology, has announced that it has signed a subcontract service agreement with HalioDx’s U.S.-based CLIA-certified laboratory located in Richmond, Virginia.

January 7, 2021

·

2 min read

Fighting Cancer with Personalized Vaccines: OncoDNA and myNEO Join Forces to Unlock the Power of mRNA Therapeutics

OncoDNA, a theranostic and genomic company specializing in precision medicine, and myNEO, an AI-driven company revolutionizing target identification within immuno-oncology, are thrilled to announce a new collaboration that will revolutionize cancer care.

April 7, 2021

·

2 min read

OncoDNA Launches OncoDEEP® Kit for Comprehensive Biomarker Testing of Solid Tumors

Unique workflow solution integrating a comprehensive pan-cancer NGS panel powered by Twist Bioscience and a bioinformatics software suite.

February 10, 2022

·

4 min read

Deals

OncoDNA Closes Successful Series B Investment Round

OncoDNA, the healthcare technology company making precision medicine a reality, announced that it has completed a €19 million Series B equity financing.

February 14, 2020

·

4 min read

Business

OncoDNA announces screening collaboration with Kura Oncology

OncoDNA is pleased to announce that it has signed a screening agreement with Kura Oncology, Inc.

May 23, 2018

·

4 min read

OncoDNA announces presentations of clinical study data at ESMO 2018 and new solid tumor analysis product release

Five oral and poster presentations highlight utility of OncoDNA’s comprehensive testing of cancer biomarkers and cancer treatment database

October 21, 2018

·

5 min read

Business

OncoDNA Signs Distribution Agreement with Gammaray Private Health Services in Turkey and AMS 2000 Trading Impex in Romania

Agreement demonstrates growing use of OncoDNA solutions across Europe

October 26, 2018

·

4 min read

OncoDNA included in Spanish medical oncology guidelines for diagnosis cancers of unknown primary origin

Type of genomic tumor analysis demonstrated by OncoDNA in study now included in the general guidelines for the diagnosis of cancers of unknown primary origin in Spain

October 3, 2018

·

4 min read

Business

OncoDNA is pleased to announce collaboration in the MDLUX2 program from INC (National Cancer Institute), Molecular Diagnostics Program funded by IBBL (Integrated BioBank of Luxembourg), the Fondation Cancer and the Fondatioun Kriibskrank Kanner

Molecular diagnostic programme for better cancer treatment kicks off

November 12, 2018

·

5 min read

Business

OncoDNA Signs Agreement With SOLTI To Provide Tumor Molecular Profile Analysis To Breast Cancer Patients In AGATA Screening Program

October 26, 2016

·

3 min read